Planets Sun
Planets Sun
copayimage Restrictionsapply Save now
Skip Navigation LinksHome > Tools and Resources > Race with Insulin®


Meet Charlie Kimball, The First Licensed IndyCar® Driver With Diabetes

Charlie Kimball is a successful young race car driver who has lived and breathed racing since the age of 9 when he began racing go-carts. After high school, he was accepted into Stanford University, but chose to follow his dream of becoming a race car driver.

Kimball has a history of breaking the mold. In 2005, he shattered the European stereotype that "Americans are not fast" by becoming the first American in 11 years to win a British Formula 3 race. He went on to secure 2 track records and several Formula 3 victories in both Britain and other European countries.

Diabetes diagnosis didn’t slow him down

In 2005, at age 22, everything came to a halt when Kimball was diagnosed with type 1 diabetes and had to abandon his racing program midseason. He was afraid that he would never race again, but with the help of his racing crew, his health care team, and diabetes treatment, including NovoLog® FlexPen® (insulin aspart [rDNA origin] injection), he got his diabetes under control and was back in the driver’s seat by 2008. He even claimed a podium finish in his first race since his diagnosis.

Kimball learned the importance of properly managing diabetes and proved that diabetes doesn’t have to stop anyone from accomplishing their dreams.

After 2 successful years in Firestone Indy Lights, Kimball joined the newly formed Novo Nordisk Chip Ganassi Racing team in 2011 for his rookie season in the IZOD IndyCar® Series. Kimball went on to record 2 top-10 finishes in the #83 Novo Nordisk IndyCar® and became the first driver in history with diabetes to qualify, start, and finish the Indianapolis 500.

In January 2013, Charlie impressed his crews on and off the track when he and his teammates won the Rolex 24 relay, his first win in a major touring series. Then in February, Kimball joined with Chip Ganassi Racing Teams to launch the Race with Insulin® Unites program, to support his quest to educate more people with diabetes. On August 4th, he again made history, by becoming the first driver with diabetes to win an IndyCar® race! Charlie took the checkered flag at the Honda Indy 200 at Mid-Ohio, earning his first victory at the highest level of the sport. He also ran second at the Pocono INDYCAR 500 and fourth in the Honda Indy Grand Prix of Alabama. He has been in the top 10 in more than half of his 19 races in 2013.

Preparing for races

Kimball prepares for his races by eating right, exercising, and using NovoLog® FlexPen® to help control his diabetes while managing his insulin delivery routine. On the track, Kimball’s doctor and crew watch his blood glucose levels through a wireless monitoring system attached to his arm. If his levels go too low, he can sip a sugar-infused drink from his helmet to bring them back up. Kimball and his crew rigorously prepare before each race to ensure that his body runs smoothly—just like his car.

Charlie Kimball continues to race in one of the most competitive categories in the world, proving that living with diabetes doesn’t slow him down.

Visit Charlie Kimball’s Web site.

IndyCar® is a registered trademark of Brickyard Trademarks, Inc.

Indications and Usage

What is NovoLog® (insulin aspart [rDNA origin] injection)?

  • NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

Who should not take NovoLog®?

Do not take NovoLog® if:

  • your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

Before taking NovoLog®, tell your health care provider about all your medical conditions including, if you are:

  • pregnant, plan to become pregnant, or are breastfeeding.
  • taking new prescription or over-the-counter medicines, including supplements.

Talk to your health care provider about how to manage low blood sugar.

How should I take NovoLog®?

  • Read the Instructions for Use and take exactly as directed.
  • NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not share needles, insulin pens, or syringes. You may give or get an infection from another person.

What should I avoid while taking NovoLog®?

  • Do not drive or operate heavy machinery, until you know how NovoLog® affects you.
  • Do not drink alcohol or use medicines that contain alcohol.

What are the possible side effects of NovoLog®?

Serious side effects can lead to death, including:

Low blood sugar. Some signs and symptoms include:

  • anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache.

Your insulin dose may need to change because of:

  • weight gain or loss, increased stress, illness, or change in diet or level of physical activity.

Other common side effects may include:

  • low potassium in your blood, injection site reactions, itching, rash, serious whole body allergic reactions, skin thickening or pits at the injection site, weight gain, and swelling of your hands and feet.

Get emergency medical help if you have:

  • trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

For more information, please click here for complete NovoLog® Prescribing Information.

NovoLog® is a prescription medicine.

Talk to your doctor about the importance of diet and exercise in your treatment plan.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

PPA Logo Rev
If you need assistance with prescription drug costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.

Selected Important Safety Information

Who should not take NovoLog®?

Do not take NovoLog® if:

  • your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

How should I take NovoLog®?

  • Read the Instructions for Use and take exactly as directed.
  • NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it.
  • Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to.
  • Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.
  • Do not share needles, insulin pens, or syringes. You may give or get an infection from another person.

Please click here for additional Important Safety Information

Charlie Kimballʼs story
(3:00 min.)

Individual results may vary.
Pen art

Email to a Friend:

email icon

To(;):

From:

Message: